Walgreens Lowers Financial Outlook Amid Weaker Retail Consumer Spending
The drugstore chain says it will step up cost-cutting measures and boost the long-term profitability of its healthcare business. Source...
Vaccines
FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Moderna’s Earnings, Revenue Fall on Fewer Covid Vaccine Sales
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales. Source link
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
The company said it would apply in coming months for U.S. regulatory approval. Source link
Merck Is Coming for Pfizer’s Pneumonia Vaccine Market Share
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
Covid-19 Vaccine Rollout Carries Lessons for Pharma Supply Chains, Says Pfizer Executive
The concentrated effort to develop, manufacture and distribute vaccines as the Covid-19 pandemic began to rage across the world highlighted...
Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon
U.S. health regulators cleared use of retooled Covid-19 vaccines that target the latest versions of Omicron, in preparation for a...
U.K. Approves Covid-19 Booster Shot Aimed at Omicron
The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, paving the way...
CDC Recommends Novavax’s Covid Vaccine for Adults 18 and Older
The Centers for Disease Control and Prevention on Tuesday recommended the use of Novavax Inc.’s Covid-19 vaccine, the final hurdle...
Pfizer’s Omicron-Targeting Covid-19 Vaccines Generate Stronger Immune Response
Pfizer Inc. and BioNTech SE vaccines modified to target the Omicron variant produced a significantly larger immune response than the...
FDA Advisers Review Pfizer, Moderna Covid-19 Vaccines in Young Children
A positive recommendation would likely lead soon to expanding the U.S. Covid-19 vaccination campaign to the 19.6 million children 6...
Three-Dose Pfizer Covid Vaccine Works Safely in Young Children, Review Says
The FDA staff also said, in a review of study data posted online Sunday, that there were no new safety...
Moderna Seeks to Dismiss Covid-19 Vaccine Patent Lawsuit
Moderna Inc. is trying to fend off rival companies’ claims that its Covid-19 vaccine infringes their patents, arguing that the...
FDA Limits Authorized Use of J&J’s Covid-19 Vaccine
The Food and Drug Administration limited the use of the Covid-19 vaccine from Johnson and Johnson after reviewing the risk...
Biotech Stocks, Once Booming, Enter Bear Territory
Biotech companies are having one of their worst stock-market runs in years, as rising interest rates, scientific setbacks and a...
Masks Come Off, Mandates Loosen as Companies Relax Covid-19 Protocols
U.S. companies are relaxing many of the vaccine and other Covid-related requirements that had become a staple of corporate life...
Moderna Beats Profit Estimates, Fueled by Covid-19 Vaccine Sales
Moderna Inc. posted better-than-expected profits for the last three months of 2021 as the company’s Covid-19 vaccine continued to power...
Sanofi, Glaxo Seek Covid-19 Vaccine Approval in Crowded Market
Sanofi SA and GlaxoSmithKline PLC said they would seek authorization for their Covid-19 vaccine, a sign that pharmaceutical companies still...
Pfizer Forecasts $54 Billion in 2022 Sales From Its Covid-19 Vaccine, Treatment
As Pfizer Inc. PFE -2.84% forecasts strong sales this year for its Covid-19 vaccine and treatment, the drugmaker is on...
